Alcohol may interfere with the contractility of heart muscle cells, change the shape and structure of heart muscle cells, contribute to electrolyte imbalance, or induce oxidative stress
Your GP or specialist will consider your complete medical history, current medications, and treatment goals before recommending this combination
Tirzepatide (Mounjaro/Zepbound) Tirzepatide is a dual GIP/GLP-1 receptor agonist that produces even greater weight loss than Semaglutide (average 20-22% of body weight)
On a Retatrutide 2.0 pen, 3 clicks = 0.5mg and 6 clicks = 1mg so a 40mg pen has roughly 240 clicks in it
Regular clinical review should include: Assessment of weight loss trajectory and nutritional status Evaluation of fall risk, particularly in older adults Review of concomitant medications affecting bone health Monitoring for new fractures or bone pain When to seek medical advice : Patients should contact their GP if they experience unexplained bone pain, height loss, new fractures from minimal trauma, or concerns about rapid weight loss